Showing posts with label Supervised Injection Facility. Show all posts
Showing posts with label Supervised Injection Facility. Show all posts

Wednesday, December 30, 2015

Use of a Medically Supervised Injection Facility among Street Youth

Purpose
Supervised injecting facilities (SIFs) provide a sanctioned space for injection drug users and are associated with decreased overdose mortality and HIV risk behaviors among adults. Little is known about SIF use among youth. We identified factors associated with use of the Vancouver SIF, the only such facility in North America, among street youth.

Methods
From September 2005 to May 2012, we collected data from the At-Risk Youth Study (ARYS), a prospective cohort of street youth in Vancouver, Canada. Eligible youth were aged 14–26 years. Participants reporting injection completed questionnaires at baseline and semiannually. We used generalized estimating equation logistic regression to identify factors associated with SIF use.

Results
During the study period, 42.3% of 414 injecting youth reported use of the SIF at least once. Of all SIF-using youth, 51.4% went to the facility at least weekly, and 44.5% used it for at least one-quarter of all injections. SIF-using youth were more likely to live or spend time in the neighborhood surrounding the SIF, to inject in public, or to engage in daily injection of heroin, cocaine, or crystal methamphetamine.

Conclusions
This study, the first examining SIF use among street youth in North America, demonstrated that the facility attracted high-frequency young drug users most at risk of blood-borne infection and overdose, and those that otherwise inject in public spaces.

TABLE 1

Characteristicsa of 414 actively injecting youth, according to use of a supervised injection facility (SIF) in the preceding 6 months: At-Risk Youth Study (ARYS), Vancouver, British Columbia, 2005–2012.
Recent SIF Use
CharacteristicYes (%)
(n = 175)
No (%)
(n = 239)
OR (95% CI)p Value
Sociodemographic factors
  Median age, years (IQR)23.4 (21.5, 25.1)22.7 (20.4, 24.5)1.14 (1.05 – 1.22)0.003
  Male112 (64.0)162 (67.8)0.85 (0.56 – 1.27)0.422
  Aboriginal ancestry45 (25.7)50 (20.9)1.31 (0.83 – 2.07)0.252
  High school education67 (40.4)94 (39.8)1.02 (0.68 – 1.53)0.915
  Spent time in DTESc,d143 (81.7)114 (47.7)4.90 (3.09 – 7.76)<0.001
  Homelessd127 (73.0)179 (75.2)0.89 (0.57 – 1.39)0.610
  Incarceratedd45 (25.9)51 (21.4)1.28 (0.81 – 2.03)0.293
  Sex workd24 (13.7)33 (13.8)0.99 (0.56 – 1.75)0.978
Drug use-related behaviors
  Daily heroin injectiond76 (43.4)49 (20.5)2.98 (1.93 – 4.59)<0.001
  Daily cocaine injectiond11 (6.3)5 (2.1)3.14 (1.07 – 9.20)0.029
  Daily crystal meth injectiond36 (20.6)34 (14.2)1.56 (0.93 – 2.62)0.089
  Overdosed29 (16.6)40 (16.7)0.99 (0.59 – 1.67)0.965
  Dealt drugsd94 (53.7)115 (48.1)1.25 (0.85 – 1.85)0.261
  Any public injectiond,e129 (73.7)147 (65.0)1.51 (0.98 – 2.33)0.063
  Needed help injectingd56 (32.0)90 (40.0)0.71 (0.47 – 1.07()0.099
  Visited crack house or shooting galleryd65 (39.9)67 (29.8)1.56 (1.02 – 2.39)0.038
  Borrowed syringed29 (16.6)42 (18.7)0.87 (0.51 – 1.46)0.586
  ‘Jacked up’ by policed68 (39.3)90 (38.0)1.06 (0.71 – 1.58)0.784
  Received drug treatmentd68 (39.3)80 (33.8)1.27 (0.85 – 1.91)0.248
aFor the 175 youth who reported SIF use, characteristics are shown for the first visit (baseline or follow-up) at which SIF use was reported; for 239 who never reported SIF use, characteristics are shown for the first visit at which injection drug use was reported
bPrior completion of or current enrollment in high school
cLived or spent time in the Downtown Eastside neighborhood, the area immediately surrounding Vancouver's SIF
dDuring the preceding six months
eOn the street, in a public bathroom, or in a park

Full article at:  http://goo.gl/SQIrpR

By:   Scott E. Hadland, MD, MPH,1,2 Kora DeBeck, PhD,3,4 Thomas Kerr, PhD,3,5 Paul Nguyen, PhD,3 Annick Simo, MSc,3Julio S. Montaner, MD,3,5 and Evan Wood, MD, PhD3,5
1Boston Children’s Hospital, Division of Adolescent and Young Adult Medicine, Department of Medicine, 300 Longwood Avenue, Boston, MA, USA, 02115
2Harvard Medical School, Department of Pediatrics, 25 Shattuck St., Boston, MA, USA, 02115
3British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608 - 1081 Burrard Street, Vancouver, BC, Canada, V6Z 1Y6
4Simon Fraser University, School of Public Policy, SFU Harbour Centre, 515 West Hastings Street, Suite 3271, Vancouver, BC, Canada, V6B 5K3
5University of British Columbia, Faculty of Medicine, 317 - 2194 Health Sciences Mall, Vancouver, BC, Canada, V6T 1Z3
Send correspondence to: Evan Wood, MD, PhD, BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608 – 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6, Phone: (604) 806-9116, Fax: (604) 806-9044, Email: ac.cbu.tenefc@we-irhu



Saturday, December 26, 2015

Negotiating Place & Gendered Violence in Canada’s Largest Open Drug Scene

Background
Vancouver’s Downtown Eastside is home to Canada’s largest street-based drug scene and only supervised injection facility (Insite). High levels of violence among men and women have been documented in this neighbourhood. This study was undertaken to explore the role of violence in shaping the socio-spatial relations of women and ‘marginal men’ (i.e., those occupying subordinate positions within the drug scene) in the Downtown Eastside, including access to Insite.

Methods
Semi-structured qualitative interviews were conducted with 23 people who inject drugs (PWID) recruited through the Vancouver Area Network of Drug Users, a local drug user organization. Interviews included a mapping exercise. Interview transcripts and maps were analyzed thematically, with an emphasis on how gendered violence shaped participants’ spatial practices.

Results
Hegemonic forms of masculinity operating within the Downtown Eastside framed the everyday violence experienced by women and marginal men. This violence shaped the spatial practices of women and marginal men, in that they avoided drug scene milieus where they had experienced violence or that they perceived to be dangerous. Some men linked their spatial restrictions to the perceived 'dope quality' of neighbourhood drug dealers to maintain claims to dominant masculinities while enacting spatial strategies to promote safety. Environmental supports provided by health and social care agencies were critical in enabling women and marginal men to negotiate place and survival within the context of drug scene violence. Access to Insite did not motivate participants to enter into “dangerous” drug scene milieus but they did venture into these areas if necessary to obtain drugs or generate income.

Conclusion
Gendered violence is critical in restricting the geographies of men and marginal men within the street-based drug scene. There is a need to scale up existing environmental interventions, including supervised injection services, to minimize violence and potential drug-related risks among these highly-vulnerable PWID.

...Women commonly spoke of the additional risks of violent sexual assault. For example, one woman in her late twenties who engaged daily in outdoor sex work noted:

I’ll smoke [crack cocaine] in the alley and I hate it…It’s scary. Anybody could walk up behind you with something and beat you and try to rob you ‘cause they want your drugs. It’s just scary…I’ve been raped [in an alleyway].

Gendered violence was understood to be a natural consequence of drug scene involvement, and thus operated as a form of symbolic violence. Many participants expressed that this normalized, gendered violence was most evident in the expectation that dominant men would seek to control the money and drugs or labour (e.g., contexts in which they exchanged sex) of women and marginal men. For example, as one older man noted during his interview:

The girls make the money [through involvement in sex work]. Guys know they got the money. The guys don’t make money, and that way they have to beg, borrow or steal in between cheques…So, of course they [women] are going to be manipulated…These guys, you know, [are] muscling them or doing anything to get what they’ve got [i.e., drugs or money]...


Full article at: 

1BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada
2Department of Medicine, University of British Columbia, Vancouver, British Columbia Canada
3Vancouver Area Network of Drug Users, Vancouver, British Columbia, Canada
4Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada
   


Self-Reported Changes in Drug Use Behaviors & Syringe Disposal Methods Following the Opening of a Supervised Injecting Facility in Copenhagen, Denmark

Background
In Denmark, the first standalone supervised injecting facility (SIF) opened in Copenhagen’s Vesterbro neighborhood on October 1, 2012. The purpose of this study was to assess whether use of services provided by the recently opened SIF was associated with changes in injecting behavior and syringe disposal practices among people who inject drugs (PWID). We hypothesized that risk behaviors (e.g., syringe sharing), and unsafe syringe disposal (e.g., dropping used equipment on the ground) had decreased among PWID utilizing the SIF.

Methods
Between February and August of 2013, we conducted interviews using a survey (in English and Danish) with forty-one people who reported injecting drugs at the SIF. We used descriptive statistics and McNemar’s test to examine sociodemographic characteristics of the sample, current drugs used, sites of syringe disposal before and after opening of the SIF, and perceived behavior change since using the SIF.

Results
Of the interviewed participants, 90.2% were male and the majority were younger than 40 years old (60.9%). Three-quarters (75.6%) of participants reported reductions in injection risk behaviors since the opening of the SIF, such as injecting in a less rushed manner (63.4%), fewer outdoor injections (56.1%), no longer syringe sharing (53.7%), and cleaning injecting site(s) more often (43.9%). Approximately two-thirds (65.9%) of participants did not feel that their frequency of injecting had changed; five participants (12.2%) reported a decrease in injecting frequency, and only two participants (4.9%) reported an increase in injecting frequency. Twenty-four (58.5%) individuals reported changing their syringe disposal practices since the opening of the SIF; of those, twenty-three (95.8%) reported changing from not always disposing safely to always disposing safely (McNemar’s test p-value < 0.001).

Conclusions
Our findings suggest that use of the Copenhagen SIF is associated with adoption of safer behaviors that reduce harm and promote health among PWID, as well as practices that benefit the Vesterbro neighborhood (i.e., safer syringe disposal). As a public health intervention, Copenhagen’s SIF has successfully reached PWID engaging in risk behavior. To fully characterize the impacts of this and other Danish SIFs, further research should replicate this study with a larger sample size and prospective follow-up.

Table 2

Primary locations for disposal of used syringes among a sample of people who inject drugs before and after the opening of a supervised injecting facility in Copenhagen, Denmark ( n  = 41)
Disposal mechanism/siteBefore SIF opened n (%)After SIF opened n (%)
Returned to the needle exchange (or SIF)14 (34.1)36 (87.8)
Put them in an outdoors sharps container19 (46.3)8 (19.5)
Put them in their own sharps container11 (26.8)6 (14.6)
Threw them in the garbage23 (56.1)5 (12.2)
Dropped them on the ground5 (12.2)0 (0.0)
Gave them to another user2 (4.9)0 (0.0)
Flushed them down the toilet4 (9.8)0 (0.0)
Other3 (7.3)0 (0.0)
Note: n’s do not sum to 41 and proportions do not sum to 100% because participants may have identified more than one location as primary site of used syringe disposal.
Note: all data collected between February and August, 2013.

Table 3

Perceived behavior and frequency change among a sample of people who inject drugs at a supervised injecting facility since its opening in Copenhagen, Denmark ( n  = 41)
Characteristicn (%)
Any perceived behavior change31 (75.6)
 Less rushed/stressful26 (63.4)
 Less injecting outdoors23 (56.1)
 No longer share needles22 (53.7)
 Clean injection site more often18 (43.9)
 Easier to get vein first time16 (39.0)
 Reuse own needles less often11 (26.8)
 Use clean water more often11 (26.8)
 No longer need help injecting6 (14.6)
 Other3 (7.3)
Perceived frequency change
 No change27 (65.9)
 Decreased (inject less often)5 (12.2)
 Increased (inject more often)2 (4.9)
 Unsure4 (9.8)
Note: n’s do not sum to 41 and proportions do not sum to 100% due to missing values or where participants endorsed more than one option.
Note: all data collected between February and August, 2013.
Full article at:   http://goo.gl/2IuC7S

By:   Elizabeth N Kinnard,corresponding author Chanelle J Howe, Thomas Kerr, Vibeke Skjødt Hass, and Brandon DL Marshall
Department of Behavioral and Social Sciences, Brown University School of Public Health, 121 South Main Street, Box G-S-121-4 Providence, RI 02912 USA
Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Box G-S-121-2, Providence, RI 02912 USA
Faculty of Medicine, University of British Columbia, 317 - 2194 Health Sciences Mall, Vancouver, BC V6T 1Z3 Canada
Urban Health Research Initiative, British Columbia Centre for Excellence in HIV/AIDS, 608 – 1081 Burrard Street, Vancouver, BC V6Z 1Y6 Canada
The Saxo Institute, Faculty of Humanities, University of Copenhagen, Karen Blixens Vej 4, DK-2300 Copenhagen, Denmark
Elizabeth N Kinnard, Email: ude.nworb@dranniK_htebazilE.

  


Willingness to Access an In-Hospital Supervised Injection Facility among Hospitalized People Who Use Illicit Drugs

BACKGROUND:
Despite the reliance on abstinence-based drug policies within hospital settings, illicit drug use is common among hospitalized patients with severe drug addiction. Hospitalized patients who use illicit drugs (PWUDs) have been known to resort to high-risk behavior to conceal their drug use from healthcare providers. Novel interventions with the potential to reduce high-risk behavior among PWUDs in hospital settings have not been well studied.

OBJECTIVE:
The objective of the study was to examine factors associated with willingness to access an in-hospital supervised injection facility (SIF).

DESIGN:
Data were derived from participants enrolled in 2 Canadian prospective cohort studies involving PWUDs between June 2013 and November 2013. A cross-sectional study surveying various sociodemographic characteristics, drug use patterns, and experiences was conducted.

SETTING:
Vancouver, Canada.

MEASUREMENTS:
Bivariable and multivariable logistic regression analyses were used to explore factors significantly associated with willingness to access an in-hospital SIF.

RESULTS:
Among 732 participants, 499 (68.2%) would be willing to access an in-hospital SIF. In multivariable analyses, factors positively and significantly associated with willingness to access an in-hospital SIF included: daily heroin injection (adjusted odds ratio [AOR] = 1.90; 95% confidence interval [CI]: 1.20-3.11); having used illicit drugs in hospital (AOR = 1.63; 95% CI: 1.18-2.26); and having recently used an SIF (AOR = 1.53; 95% CI: 1.10-2.15).

CONCLUSIONS:
Our findings highlight the potential of in-hospital SIFs to complement existing harm reduction programs that serve PWUD. Moreover, an in-hospital SIF may minimize the harms associated with high-risk illicit drug use in the hospital.

Purchase full article at:   http://goo.gl/86AYux

  • 1British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.